Noxopharm Ltd
ASX:NOX
Noxopharm Ltd
ASX:NOX
Price:
0.061
AUD
-6.15%
Market Closed
Market Cap:
AU$17.8m
Balance Sheet
Balance Sheet Decomposition
Noxopharm Ltd
Noxopharm Ltd
Balance Sheet Decomposition is not available for
Noxopharm Ltd
Noxopharm Ltd
Balance Sheet
Noxopharm Ltd
Noxopharm Ltd
Currency: AUD
| Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
2
|
13
|
3
|
7
|
27
|
14
|
3
|
|
| Cash |
0
|
0
|
0
|
0
|
7
|
17
|
6
|
3
|
|
| Cash Equivalents |
0
|
2
|
13
|
3
|
0
|
10
|
8
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
5
|
6
|
5
|
6
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
5
|
6
|
5
|
6
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
0
|
2
|
0
|
|
| Total Current Assets |
0
|
3
|
14
|
4
|
12
|
33
|
21
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
7
|
14
|
5
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
3
+777%
|
15
+414%
|
4
-70%
|
20
+367%
|
48
+138%
|
27
-44%
|
10
-62%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
2
|
6
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
6
|
7
|
7
|
2
|
1
|
|
| Long-Term Debt |
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+22%
|
4
+1 119%
|
4
0%
|
7
+63%
|
7
-2%
|
2
-65%
|
1
-57%
|
|
| Equity | |||||||||
| Common Stock |
1
|
6
|
28
|
29
|
42
|
73
|
75
|
75
|
|
| Retained Earnings |
1
|
4
|
18
|
29
|
29
|
32
|
51
|
66
|
|
| Total Equity |
0
N/A
|
2
+9 427%
|
10
+311%
|
0
N/A
|
13
N/A
|
41
+217%
|
24
-41%
|
9
-62%
|
|
| Total Liabilities & Equity |
0
N/A
|
3
+777%
|
15
+414%
|
4
-70%
|
20
+367%
|
48
+138%
|
27
-44%
|
10
-62%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
62
|
96
|
138
|
139
|
213
|
288
|
292
|
292
|
|
Switch to:
Switch to:
See Also
Discover More
